| Odor identification as a biomarker of preclinical AD in older adults at risk ME Lafaille-Magnan, J Poirier, P Etienne, J Tremblay-Mercier, J Frenette, ... Neurology 89 (4), 327-335, 2017 | 107 | 2017 |
| INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease PF Meyer, J Tremblay-Mercier, J Leoutsakos, C Madjar, ... Neurology 92 (18), e2070-e2080, 2019 | 104 | 2019 |
| Subjective cognitive decline is associated with altered default mode network connectivity in individuals with a family history of Alzheimer’s disease SCJ Verfaillie, AP Binette, E Vachon-Presseau, S Tabrizi, M Savard, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 3 (5), 463-472, 2018 | 51 | 2018 |
| Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer’s disease P Orban, C Madjar, M Savard, C Dansereau, A Tam, S Das, AC Evans, ... Scientific data 2 (1), 1-11, 2015 | 34 | 2015 |
| Amyloid and tau pathology associations with personality traits, neuropsychiatric symptoms, and cognitive lifestyle in the preclinical phases of sporadic and autosomal dominant … AP Binette, É Vachon-Presseau, J Morris, R Bateman, T Benzinger, ... Biological psychiatry 89 (8), 776-785, 2021 | 30 | 2021 |
| Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation J Miron, C Picard, MÉ Lafaille-Magnan, M Savard, A Labonté, J Breitner, ... Alzheimer's & Dementia 15 (7), 951-960, 2019 | 24 | 2019 |
| Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer’s disease J Tremblay-Mercier, C Madjar, S Das, AP Binette, SOM Dyke, P Étienne, ... NeuroImage: Clinical 31, 102733, 2021 | 22 | 2021 |
| APOE4 status is related to differences in memory-related brain function in asymptomatic older adults with family history of Alzheimer’s disease: Baseline analysis of the … S Rabipour, S Rajagopal, E Yu, S Pasvanis, ME Lafaille-Magnan, ... Journal of Alzheimer's Disease 76 (1), 97-119, 2020 | 10 | 2020 |
| Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment C Strikwerda-Brown, DA Hobbs, J Gonneaud, F St-Onge, AP Binette, ... JAMA neurology 79 (10), 975-985, 2022 | 9 | 2022 |
| Odor identification as a biomarker for progression of pre-symptomatic Alzheimer's disease ME Lafaille-Magnan McGill University (Canada), 2018 | 2 | 2018 |
| O1‐12‐05: Olfactory identification correlates with cerebral blood flow in cognitively normal adults at risk of Alzheimer's dementia ME Lafaille-Magnan, C Madjar, R Hoge, JCS Breitner, ... Alzheimer's & Dementia 11 (7S_Part_3), P160-P161, 2015 | 2 | 2015 |
| P1‐585: CROSSTALK BETWEEN ENGLISH AND FRENCH FORMS OF THE RBANS IN AN ALZHEIMER'S DISEASE PREVENTION TRIAL ME Lafaille-Magnan, JMS Leoutsakos, D Fontaine, C Madjar, J Kat, ... Alzheimer's & Dementia 14 (7S_Part_10), P559-P560, 2018 | 1 | 2018 |
| P4‐119: Olfactory identification is associated with verbal intrusion and primacy effects in cognitively normal adults at risk of Alzheimer's dementia ME Lafaille-Magnan, D Fontaine, JCS Breitner, ... Alzheimer's & Dementia 11 (7S_Part_18), P823-P824, 2015 | 1 | 2015 |
| O2‐08‐06: PONDER: A cognitive training and prevention program—design, methodology, and first results T Beaudry, ME Lafaille-Magnan, JC Pruessner Alzheimer's & Dementia 11 (7S_Part_4), P193-P194, 2015 | 1 | 2015 |
| IC‐P‐149: ASSOCIATION OF OLFACTORY PERFORMANCE AND HIPPOCAMPAL VOLUME IN PERSONS AT RISK OF ALZHEIMER'S DEMENTIA ME Lafaille‐Magnan, L Collins, V Fonov, D Fontaine, P Etienne, J Poirier, ... Alzheimer's & Dementia 10, P85-P86, 2014 | 1 | 2014 |
| P1–160: Olfactory identification as a potential marker of presymptomatic Alzheimer's disease ME Lafaille‐Magnan, J Breitner, P Etienne, J Poirier, D Fontaine, ... Alzheimer's & Dementia 9, P208-P208, 2013 | 1 | 2013 |
| Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition H Ozlen, AP Binette, T Köbe, PF Meyer, J Gonneaud, F St-Onge, ... JAMA neurology 79 (10), 1025-1035, 2022 | | 2022 |
| Odor identification as a useful marker of presymptomatic AD ME Lafaille-Magnan, JCS Breitner | | 2022 |
| THE OLFACT TEST BATTERY (OTB) PREDICTS ALZHEIMER’S DISEASE RSW Lloyd Hastings, Marie-Elyse Lafaille-Magnan, Steven Howe Clinical Trials on Alzheimer's Disease 6 (The Journal of Prevention of …, 2019 | | 2019 |
| " INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease": Correction. PF Meyer, J Tremblay-Mercier, J Leoutsakos, C Madjar, ... Lippincott Williams & Wilkins, 2019 | | 2019 |
John BreitnerProfessor of Psychiatry, McGill University Faculty of MedicineVerified email at mcgill.ca
